NCT01970254View on ClinicalTrials.gov

Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy

CompletedOBSERVATIONAL
Enrollment

2,206

Participants

Timeline

Start Date

June 24, 2013

Primary Completion Date

July 19, 2022

Study Completion Date

July 19, 2022

Conditions
CancerHepatitis BHBVHepatitis B InfectionMalignant Neoplasm
Interventions
OTHER

Hepatitis B Screening

Undergo 3 HBV screening tests (HbsAg, anti-HBc, and anti-HBs)

OTHER

Survey Administration

Ancillary studies

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT01970254 - Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy | Biotech Hunter | Biotech Hunter